| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund (G) Direct |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.08 |
| Equity |
68.83 |
| Int Equity |
31.06 |
| Trep |
0.03 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
34.32% |
| Top 10 Holdings |
55.22% |
| Top 25 Holdings |
85.49% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
53.54 |
| Global Equity |
31.06 |
| Healthcare |
15.29 |
| Cash |
0.11 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
99.38 |
| PE Ratio |
736.77 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Ltd. |
10.99 |
| Divis Laboratories Ltd. |
6.96 |
| ELI LILLY & CO |
6.34 |
| Apollo Hospitals Enterprises Ltd. |
5.51 |
| Max Healthcare Institute Limited |
4.52 |
| Torrent Pharmaceuticals Ltd. |
4.45 |
| Cipla Ltd. |
4.38 |
| JOHNSON & JOHNSON |
4.37 |
| Laurus Labs Limited |
4.14 |
| Dr. Reddys Laboratories Ltd. |
3.56 |
| ABBVIE INC |
3.10 |
| Lupin Ltd |
3.08 |
| Aurobindo Pharma Ltd. |
2.76 |
| Fortis Healthcare Ltd |
2.74 |
| Merck & Co. Inc |
2.49 |
| Glenmark Pharmaceuticals ltd |
2.15 |
| NOVARTIS AG |
1.90 |
| Ipca Laboratories Ltd. |
1.70 |
| Biocon Ltd. |
1.64 |
| AMGEN INC |
1.58 |
| THERMO FISHER SCIENTIFIC INC |
1.57 |
| Mankind Pharma Limited |
1.54 |
| Alkem Laboratories Limited |
1.37 |
| Zydus Lifesciences Limited |
1.33 |
| Gland Pharma Limited |
1.32 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
